Short answer · Medically reviewed summary · Last updated: 2026-04-07
Anxiety disorders are considered the most common mental health conditions globally, with the World Health Organization estimating that approximately 301 million people were living with an anxiety disorder in 2019. While prevalence rates vary by region and diagnostic criteria, it is estimated that roughly 4% of the global population experiences anxiety, though these figures often underestimate true clinical prevalence due to significant barriers to diagnosis and reporting. Is anxiety considered a rare disease? Unlike many conditions mapped on DiseaseMaps.org, anxiety is not classified as a rare or ultra-rare disease.
1 people with Anxiety have shared their first-person experience on this question at DiseaseMaps.
Anxiety disorders are considered the most common mental health conditions globally, with the World Health Organization estimating that approximately 301 million people were living with an anxiety disorder in 2019. While prevalence rates vary by region and diagnostic criteria, it is estimated that roughly 4% of the global population experiences anxiety, though these figures often underestimate true clinical prevalence due to significant barriers to diagnosis and reporting.
Unlike many conditions mapped on DiseaseMaps.org, anxiety is not classified as a rare or ultra-rare disease. Instead, it is recognized as a highly prevalent public health concern. Because anxiety encompasses a spectrum of conditions—including Generalized Anxiety Disorder (GAD), Social Anxiety Disorder, and Panic Disorder—the collective prevalence is substantial. It is important to note that while anxiety is common, the impact on an individual’s quality of life can be as severe and debilitating as many rare, chronic illnesses.
Epidemiological data consistently shows that anxiety disorders are more frequently diagnosed in females than in males. According to the National Institute of Mental Health (NIMH), the lifetime prevalence of any anxiety disorder is approximately 33.7% for females compared to 22.8% for males. Regarding age of onset, anxiety typically emerges during childhood, adolescence, or early adulthood. The median age of onset is generally cited as 11 years old, making it a condition that often requires early identification and intervention to manage effectively across the lifespan.
Accurate prevalence data for anxiety is difficult to capture for several key reasons:
While large-scale epidemiological studies provide a macro view of anxiety, the 380 members who have shared their experiences on DiseaseMaps.org offer a vital, patient-centered perspective. This community data highlights that anxiety is not merely a statistical figure but a lived experience. By mapping the personal journeys of those with anxiety, DiseaseMaps.org helps bridge the gap between clinical prevalence and the nuanced reality of day-to-day management, helping others feel less isolated in their struggle.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.